<DOC>
	<DOCNO>NCT02490163</DOCNO>
	<brief_summary>In study perform 2012 , investigator demonstrate ECP setting , new automate device ( Spectra Optia-MNC ) release Terumo BCT MNCs collection base intermittent flow safe ensure high-quality MNC collection yield . ( 5 , 6 ) More recently ( 2013 ) , Terumo BCT release another automated system allow collect stem cell MNCs base continuous collection flow . ( 7 , 8 ) The aim cross-over study compare yield ( i.e . collection efficiency , CE ) quality ( i.e . purity contamination ) MNCs collect patient undergo ECP two different automate system : MNC CMNC ( Terumo BCT ) process 1.5 blood volume every collection procedure .</brief_summary>
	<brief_title>Comparison Two Automated Mononuclear Collection Systems Patients Undergoing Extracorporeal Photochemotherapy . A Cross-over Equivalence Study . ( MNC_CMNC )</brief_title>
	<detailed_description>Two-sequences-in-four-periods cross-over , patient randomize device within ECP cycle two consecutive cycle , open-label . Cycle 1 Cycle 1 Cycle 2 Cycle 2 Day 1 Day 2 Day 1 Day 2 Sequence A CMNC MNC MNC CMNC Sequence B MNC CMNC CMNC MNC There might carry effect procedure 1 2 within cycle , procedure patient administer fluid , therefore cell counts/ml second day might lower first day ; intrinsic clinical procedure modify , take account statistical analysis . Carry effect first second cycle expect , since perform least 7 day apart ; allow patient 's cell blood count restore baseline value ; however , also consider statistical analysis .</detailed_description>
	<criteria>adult ( &gt; 18 year ) patient undergo extracorporeal photochemotherapy either CLAD GvHD Inclusion criterion : age &gt; 18 year extracorporeal photochemotherapy either CLAD GvHD exclusion criterion : age &lt; 18 year ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>